Breaking News: ADCT – Market Insights, Analysis & Latest Updates

Filters

Date Range

General Sources

ADC Therapeutics shares drop after trial results

ADC Therapeutics reports encouraging results for the ZYNLONTA and glofitamab combination in treating r/r DLBCL, despite a 20% drop in share prices.

investing.com • 11/12/2024 - 16:05 PM

Greed and Fear Index

Note: The data is for reference only.

Greed